Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
521. |
ECCT/13/10/03 | The Impact of Supplementation with Iron and Vitamin B12 Singly and In Combination on Nutritional Status and Morbidity Among Primary School Children. |
Principal Investigator(s) 1. Priscilla Monyangi Dr. Nyakundi Site(s) in Kenya Kilifi County, Ganze District. |
02-02-2013 |
View |
522. |
ECCT/13/10/02 | CEM ART Cohort Event Monitoring of Antiretroviral Medicines Use in Kenya |
Principal Investigator(s) 1. Caroline Olwande 2. Irene Mukui 3. Maureen Kimani 4. Edward Abwao 5. Ndinda Kusu 6. Maureen Kimani 7. Edward Abwao 8. Ndinda Kusu Site(s) in Kenya 1. Nyeri Provincial General Hospital (Nyeri county) 2. Thika Level 5 Hospital (Kiambu county) 3. Machakos Level 5 Hospital (Machakos county) 4. Vihiga District Hospital (Vihiga county) 5. Kisii Level 5 Hospital (Kisii county) 6. St Camillus Mission Hospital (Migori county) 7. Nakuru Provincial General Hospital (Nakuru county) 8. Coast Provincial General Hospital (Mombasa county) |
30-09-2013 |
View |
523. |
ECCT/13/10/01 | Clinical Trial of Acceptability, Adherence and Biologic Effects of a Vaginal Contraceptive Ring among Women in Western Kenya |
Principal Investigator(s) 1. Fredrick Odhiambo Otieno 2. Lisa Ann Mills Site(s) in Kenya KEMRI/CDC Research and Public Health Collaboration |
27-09-2013 |
View |
524. |
ECCT/13/08/06 | Management of myocardial injury After NoncArdiac surgGEry (MANAGE) Trial |
Principal Investigator(s) 1. GERALD OCHIENG\' YONGA 2. LEONARD MZEE NGUNGA Site(s) in Kenya Aga Khan University Hospital, Nairobi |
30-11-2012 |
View |
525. |
ECCT/13/08/02 | MalPaC Trial Comparing drug-regimens for clearing parasites in Phase IIb trial designs prior to PCR monitoring for Plasmodium falciparum infection. |
Principal Investigator(s) 1. Caroline Amolo Ogwang 2. Francis Maina Ndung\'u Site(s) in Kenya Junju |
29-07-2013 |
View |
526. |
ECCT/13/08/01 | M72/AS01 E A phase IIb, double-blind, randomised, placebo-controlled study to evaluate the efficacy, safety and immunogenicity of GSK Biologicals’ candidatetuberculosis (TB) vaccine GSK 692342 against TB disease, in healthy adults aged 18-50 years, living in a TB endemic region. |
Principal Investigator(s) 1. Dr Videlis Nduba Site(s) in Kenya KEMRI-CDC |
06-08-2013 |
View |
527. |
ECCT/13/07/05 | Single Dose Escalating, Single-blind Phase 1 Trial in Healthy Male Volunteers to Evalute the Safety, Tolerability and the Pharmacokinetics of Oleylphosphocholine. |
Principal Investigator(s) 1. Rashid Ravasco Juma Site(s) in Kenya KEMRI Centre for Clinical Research |
25-06-2013 |
View |
528. |
ECCT/13/07/04 | Advanced Kapsosis Sarcoma Chemotherapy Regimens A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings |
Principal Investigator(s) 1. Josphat Kosgei Site(s) in Kenya 1. WRP/KEMRI - Kericho (Kericho county) 2. AMPATH - MOI University Teaching Hospital Eldoret CRS (Uasin Gishu county) |
07-08-2012 |
View |
529. |
ECCT/13/07/03 | Pharmacokinetic and pharmacodynamic studies of efficacy, tolerability and safety of higher dosage rifapentine for treatment of tuberculosis |
Principal Investigator(s) 1. Dr Lena Matata Site(s) in Kenya KEMRI-CDC |
07-12-2011 |
View |
530. |
ECCT/13/07/01 | HIVCORE004/N004 A phase I/IIa clinical trial of universal HIV-1 vaccines pSG2.HIVconsv DNA, MVA.HIVconsv and ChAdV63.HIVconsv in combined regimens in healthy HIV-1/2-negative adults in Nairobi. |
Principal Investigator(s) 1. Prof. Walter Godfrey Jaoko Site(s) in Kenya KAVI-KANGEMI RESEARCH SITE |
19-06-2013 |
View |